Category: Johnson Johnson

Johnson & Johnson to Split Into Two Companies, Shares Rally

Johnson & Johnson has announced plans to split into two companies, spinning off its consumer health division—which sells products like Band-Aids, Baby Powder, and Listerine—into a separate publicly traded company. The consumer health business has been provisionally dubbed the New Consumer Health Company, according to a Nov. 12 statement, while the new Johnson & Johnson…


US Judge Halts Johnson & Johnson Talc Litigation for 60 Days

CHARLOTTE, N.C.—A U.S. bankruptcy judge on Wednesday put a 60-day halt on tens of thousands of legal claims against Johnson & Johnson that allege its talc-based products cause cancer. U.S. Bankruptcy Judge Craig Whitley ordered the halt at a hearing in Charlotte, North Carolina. He also decided to transfer the talc cases to a federal…


Oklahoma Court Overturns $465 Million Opioid Judgment Against J&J

The Oklahoma Supreme Court on Tuesday overturned a $465 million judgment against Johnson & Johnson in a lawsuit by the state alleging the drugmaker fueled the opioid epidemic through the deceptive marketing of painkillers. The decision marked the latest setback for states and local governments pursuing lawsuits to hold pharmaceutical companies responsible for a drug…


Effectiveness of 2 of 3 COVID-19 Vaccines Used in US Drops Below 50 Percent: Study

The effectiveness of the three COVID-19 vaccines available in the United States has declined in recent months, with protection against infection falling under 50 percent for two of them, according to a new study. Moderna’s COVID-19 vaccine dropped from 89.2 percent in March to 58 percent in September, researchers found. During the same period of…


Effectiveness of 2 of 3 COVID-19 Vaccines Used in US Drops Below 50 Percent After 6 Months: Study

The effectiveness of the three COVID-19 vaccines available in the United States has declined in recent months, with protection against infection falling under 50 percent for two of them after six months, according to a new study. Moderna’s COVID-19 vaccine dropped from 89.2 percent in March to 58 percent in September, researchers found. During the…


GameStop COO, Dogelon Mars Surge, Snowden on Shiba Inu, J&J Settlement, Cathie Wood’s FB Bet: 5 Headlines You May Have Missed From This Weekend

Here is a quick roundup of the top five stories from the technology, corporate and cryptocurrency sectors that investors would not want to miss out on from the weekend. 1. Johnson & Johnson Settles Risperdal Lawsuits Johnson & Johnson (J&J) said it has settled most of the 9,000 lawsuits it faced over its anti-psychotic drug…


J&J COVID Vaccine Recipients See Higher Risk of Blood Clots: Mayo Clinic Study

A study published Monday said that those who received the Johnson & Johnson single-shot COVID-19 vaccine were more likely to experience a certain type of blood clotting issue than among individuals in the general population before the start of the pandemic, although researchers said that the blood clots are rare. Researchers with the Mayo Clinic, who…


New Jersey Hospital Mandates Booster Shots for Workers Who Got J&J’s COVID Vaccine

Hospitals around the nation earlier this year began imposing COVID-19 vaccine mandates, but employees were told they’d meet the requirements if they received the single-shot Johnson & Johnson (J&J) vaccine. That’s changed at a New Jersey hospital, where employees now must get a booster if they received the single-shot jab. University Hospital in Newark on…


Johnson & Johnson Settles Opioid Claims In Texas For $291.8 Million

Johnson & Johnson and its U.S.-based Janssen Pharmaceutical Companies have reached a $291.8 million settlement with the Texas state government that resolves its opioid-related claims made against the companies. What Happened Johnson & Johnson will pay its settlement sum into the Qualified Settlement Fund, which represents Texas’s allocation of the Global Prescription Opioid Litigation Settlement Agreement announced on…


CDC Endorses Boosters for Moderna, J&J, Mixing Shots

The U.S. Centers for Disease Control and Prevention (CDC) has approved booster doses of the COVID-19 vaccines of the Moderna and Johnson & Johnson brands, including taking different shots for the booster compared to the initial inoculation. CDC Director Dr. Rochelle Walensky gave her final approval late Thursday after an advisory panel unanimously endorsed the boosters,…